- Home
- OPTX vs NRSN Comparison
OPTX vs NRSN Comparison
Compare OPTX & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- NRSN
- Stock Information
- Founded
- OPTX 1981
- NRSN 2017
- Country
- OPTX United States
- NRSN Israel
- Employees
- OPTX N/A
- NRSN N/A
- Industry
- OPTX Blank Checks
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- NRSN Health Care
- Exchange
- OPTX Nasdaq
- NRSN Nasdaq
- Market Cap
- OPTX 51.9M
- NRSN 58.8M
- IPO Year
- OPTX N/A
- NRSN 2021
- Fundamental
- Price
- OPTX $1.35
- NRSN $1.94
- Analyst Decision
- OPTX
- NRSN Buy
- Analyst Count
- OPTX 0
- NRSN 2
- Target Price
- OPTX N/A
- NRSN $14.00
- AVG Volume (30 Days)
- OPTX 73.0K
- NRSN 442.8K
- Earning Date
- OPTX 08-13-2025
- NRSN 07-11-2025
- Dividend Yield
- OPTX N/A
- NRSN N/A
- EPS Growth
- OPTX N/A
- NRSN N/A
- EPS
- OPTX 0.00
- NRSN N/A
- Revenue
- OPTX $29,392,186.00
- NRSN N/A
- Revenue This Year
- OPTX N/A
- NRSN N/A
- Revenue Next Year
- OPTX N/A
- NRSN N/A
- P/E Ratio
- OPTX $846.97
- NRSN N/A
- Revenue Growth
- OPTX 4.00
- NRSN N/A
- 52 Week Low
- OPTX $0.85
- NRSN $0.51
- 52 Week High
- OPTX $5.10
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- OPTX 45.66
- NRSN 47.36
- Support Level
- OPTX $1.27
- NRSN $1.77
- Resistance Level
- OPTX $1.47
- NRSN $2.35
- Average True Range (ATR)
- OPTX 0.11
- NRSN 0.25
- MACD
- OPTX -0.00
- NRSN -0.08
- Stochastic Oscillator
- OPTX 30.61
- NRSN 12.47
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.